Exploring Senti Biosciences, Inc. (SNTI) Investor Profile: Who’s Buying and Why?

Have you ever wondered who is investing in Senti Biosciences, Inc. (SNTI), and more importantly, why? As of April 11, 2025, the share price stood at $3.26, a slight decrease from $3.39 on April 12, 2024. Institutional investors hold a total of 859,131 shares. Recent data indicates strong momentum, with a 22.51% year-to-date gain. In December 2024 and January 2025, Senti Biosciences secured approximately $47.6 million through a private placement equity financing, led by Celadon Partners, with participation from New Enterprise Associates, Leaps by Bayer, and others. Additionally, the company received $6.4 million from the California Institute for Regenerative Medicines (CIRM) out of an $8 million grant. What does this influx of capital mean for the future of Senti Bio and its investors?

Senti Biosciences, Inc. (SNTI) Who Invests in Senti Biosciences, Inc. (SNTI) and Why?

Understanding the investor profile of Senti Biosciences, Inc. (SNTI) involves examining the various types of investors, their motivations, and the strategies they employ. This insight is crucial for current and prospective shareholders looking to align their investment approach with the broader market sentiment towards Senti Biosciences, Inc. (SNTI).

Key investor types in Senti Biosciences, Inc. (SNTI) typically include:

• Retail Investors: Individual investors who buy and sell shares for their own accounts.
• Institutional Investors: Entities such as mutual funds, pension funds, and insurance companies that invest on behalf of their clients.
• Hedge Funds: Investment partnerships that use pooled funds and employ various strategies to earn active return for their investors.

These investor groups often have differing investment horizons, risk tolerances, and expectations for returns, which collectively influence Senti Biosciences, Inc. (SNTI)’s stock performance.

Investment motivations for investing in Senti Biosciences, Inc. (SNTI) can vary widely:

• Growth Prospects: Investors are often attracted to Senti Biosciences, Inc. (SNTI) due to its potential for high growth, driven by its innovative technology, market expansion, or increasing demand for its products or services.
• Market Position: A strong competitive position in the market can make Senti Biosciences, Inc. (SNTI) an attractive investment, as it suggests stability and potential for sustained profitability.

To further illustrate, here's a general overview of potential investment strategies employed by different investor types:

• Long-Term Holding: Some investors adopt a long-term holding strategy, maintaining their positions in Senti Biosciences, Inc. (SNTI) for extended periods to benefit from the company's growth and potential capital appreciation.
• Short-Term Trading: Other investors engage in short-term trading, seeking to profit from short-term price fluctuations in Senti Biosciences, Inc. (SNTI)’s stock.
• Value Investing: Value investors may be attracted to Senti Biosciences, Inc. (SNTI) if they believe the stock is undervalued by the market, buying shares with the expectation that the market will eventually recognize its true worth.

Understanding the composition and strategies of Senti Biosciences, Inc. (SNTI)'s investor base can provide valuable insights into market sentiment and potential future stock performance. While specific, up-to-date details on Senti Biosciences, Inc. (SNTI)’s investor profile would require access to real-time financial data and reports, this overview provides a foundational understanding of the key factors influencing investment decisions.

Explore more about Senti Biosciences, Inc. (SNTI): Senti Biosciences, Inc. (SNTI): History, Ownership, Mission, How It Works & Makes Money

Senti Biosciences, Inc. (SNTI) Institutional Ownership and Major Shareholders

Institutional ownership in Senti Biosciences, Inc. (SNTI) provides insights into the company's stability and investor confidence. Large institutional investors often have significant resources to conduct thorough research, and their investment decisions can significantly influence the stock price.

As of the latest available data, several institutional investors hold substantial positions in Senti Biosciences, Inc. (SNTI). Here's a look at some of the top holders:

• Vanguard Group Inc.: As of March 31, 2024, Vanguard Group Inc. holds 2,184,968 shares, representing 7.83% ownership.
• BlackRock Fund Advisors: According to the latest filings, BlackRock Fund Advisors owns 1,249,916 shares.
• State Street Global Advisors, Inc.: State Street Global Advisors, Inc. holds 744,938 shares as of March 31, 2024.
• Geode Capital Management LLC: Geode Capital Management LLC's latest holdings show 480,080 shares.
• Citadel Advisors LLC: Citadel Advisors LLC reported holding 349,497 shares.

These major institutional holders play a crucial role in Senti Biosciences, Inc. (SNTI)'s stock performance and overall strategy. Their decisions to increase or decrease their positions can signal market sentiment and influence other investors.

Changes in institutional ownership can provide valuable insights into the evolving perspectives on a company's prospects. Recent transactions by major holders often reflect their assessment of the company's performance, strategic direction, and industry outlook.

Examining recent changes in ownership reveals the shifting dynamics among institutional investors:

• Some institutions may have increased their holdings, signaling confidence in Senti Biosciences, Inc. (SNTI)'s future growth potential.
• Conversely, others may have reduced their positions, possibly due to concerns about market conditions, company performance, or alternative investment opportunities.
• Tracking these changes over time helps to identify trends and potential shifts in market sentiment.

Here is a summary of institutional ownership trends for Senti Biosciences, Inc. (SNTI):

Institutional investors' actions can have a pronounced effect on Senti Biosciences, Inc. (SNTI)'s stock price and strategic direction. Their substantial holdings mean that buying and selling activity can create significant price movements.

• Increased institutional buying can drive up the stock price, reflecting positive sentiment and attracting additional investors.
• Conversely, large-scale selling by institutions can exert downward pressure on the stock price, potentially triggering broader market concerns.

Moreover, institutional investors often engage with company management, providing input on strategic decisions and corporate governance matters. This engagement can influence the company's policies and long-term planning.

More insights about Senti Biosciences, Inc. (SNTI) can be found here: Senti Biosciences, Inc. (SNTI): History, Ownership, Mission, How It Works & Makes Money

Senti Biosciences, Inc. (SNTI) Key Investors and Their Impact on Senti Biosciences, Inc. (SNTI)

Understanding the investor profile of Senti Biosciences, Inc. (SNTI) provides valuable insights into the company's stability, growth potential, and strategic direction. Key investors can significantly influence company decisions and stock movements through their investment activities and strategic perspectives.

Here's an overview of notable investors in Senti Biosciences, Inc. (SNTI) and their potential impact:

• Notable Investors: Several institutions and individuals hold significant stakes in Senti Biosciences, Inc. (SNTI). These include:
  • NEA Management Company, LLC
  • ARKG - ARK Genomic Revolution ETF
  • Vanguard Group Inc
  • Renaissance Technologies LLC
  • Geode Capital Management, Llc
  • Celadon Partners
  • Leaps by Bayer

These major shareholders can include individual investors, mutual funds, hedge funds, or institutions.

According to WallStreetZen, Omid Farokhzad is the largest individual shareholder, owning 9.13M shares, representing 198.93% of the company. New Enterprise Associates 15 LP holds 96.46%.

Fintel reports that institutions hold a total of 859,131 shares.

Nasdaq.com reports the following institutional holdings as of December 31, 2024:

• Nea Management Company, Llc: 442,615 shares
• 8Vc Gp I, Llc: 253,755 shares
• Vanguard Group Inc: 97,467 shares
• Renaissance Technologies Llc: 51,600 shares
• Geode Capital Management, Llc: 27,494 shares

Investor Influence: Investors with substantial holdings can exert influence on company decisions through their voting rights and engagement with the management team. For instance, Schedule 13D filings indicate investors who intend to actively pursue changes in business strategy, while Schedule 13G filings suggest a passive investment of over 5%.

The influence of major investors can also impact stock movements. Positive or negative sentiment from these investors can drive trading activity and affect the company's stock price.

Recent Moves: Senti Biosciences, Inc. (SNTI) has seen recent activity in private placement equity financing. In December 2024, the company announced an oversubscribed private placement, raising gross proceeds of approximately $37.6 million. An additional $10.0 million was raised later that month. This financing, led by Celadon Partners, with participation from New Enterprise Associates (NEA), Leaps by Bayer, and other institutional investors, is intended to fund the continued development of the SENTI-202 program, manufacturing ramp-up, and other research and development activities.

Senti Biosciences, Inc. (SNTI) reported that the financing is expected to extend the company's financial runway into 2026.

Here is a table summarizing some key financial data from Senti Biosciences, Inc. (SNTI) based on the fourth quarter and full year 2024 results:

For more insights into Senti Biosciences, Inc. (SNTI), explore this resource: Senti Biosciences, Inc. (SNTI): History, Ownership, Mission, How It Works & Makes Money

Senti Biosciences, Inc. (SNTI) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions to Senti Biosciences, Inc. (SNTI) is crucial for assessing the company's current position and future prospects. Recent shifts in ownership and the perspectives of market analysts can significantly influence the stock's performance.

The stock market's response to Senti Biosciences, Inc. (SNTI) is influenced by various factors, including:

• Major Investor Moves: Significant changes in ownership by institutional investors or large shareholders often trigger market reactions. An increase in holdings by reputable investors can signal confidence in the company's future, potentially driving up the stock price. Conversely, a large sell-off may indicate concerns, leading to a price decline.
• Company Performance and News: Announcements of clinical trial results, partnerships, or regulatory milestones play a vital role. Positive news generally results in a favorable market response, while negative news can have the opposite effect.
• Broader Market Trends: Overall market conditions and investor sentiment toward the biotechnology sector can also impact Senti Biosciences, Inc. (SNTI). A bullish market may lift the stock, while a bearish market can exert downward pressure.

Analyst perspectives provide valuable insights into how key investors influence Senti Biosciences, Inc. (SNTI)'s future. Analysts typically assess the impact of major shareholders based on:

• Long-Term Vision: Analysts evaluate whether major investors' strategies align with the company's long-term goals. Investors with a track record of supporting innovative biotech companies may be seen as a positive influence.
• Resource Commitment: The financial resources and expertise that key investors bring to the table are also considered. Investors with deep pockets can provide crucial funding for research and development, while those with industry expertise can offer strategic guidance.
• Potential Conflicts of Interest: Analysts also look for any potential conflicts of interest that major investors may have. For example, if a major shareholder also has significant holdings in competing companies, it could raise concerns about their commitment to Senti Biosciences, Inc. (SNTI).

To gain more insights into the company's background, mission, and ownership structure, refer to Senti Biosciences, Inc. (SNTI): History, Ownership, Mission, How It Works & Makes Money.